Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

FDA updates labeling for HYDROCODONE BITARTRATE AND ACETAMINOPHEN

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 32
  • 0 comments

Labeling changes approved for ABHAI LLC. Active ingredient: ACETAMINOPHEN; HYDROCODONE BITARTRATE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 32
  • 0 comments

Labeling changes approved for WES PHARMA INC. Active ingredient: BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for METHADONE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 33
  • 0 comments

Labeling changes approved for SUN PHARM INDUSTRIES. Active ingredient: METHADONE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 42
  • 0 comments

Labeling changes approved for LANNETT CO INC. Active ingredient: BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for NUCYNTA

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 34
  • 0 comments

Labeling changes approved for COLLEGIUM PHARM INC. Active ingredient: TAPENTADOL HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for OXYCODONE AND ACETAMINOPHEN

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 31
  • 0 comments

Labeling changes approved for LANNETT CO INC. Active ingredient: ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for NALBUPHINE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 28
  • 0 comments

Labeling changes approved for RISING. Active ingredient: NALBUPHINE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for HYDROCODONE BITARTRATE AND ACETAMINOPHEN

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 36
  • 0 comments

Labeling changes approved for TRIS PHARMA INC. Active ingredient: ACETAMINOPHEN; HYDROCODONE BITARTRATE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for MORPHINE SULFATE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 42
  • 0 comments

Labeling changes approved for UPSHER SMITH LABS. Active ingredient: MORPHINE SULFATE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for METHADONE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 27
  • 0 comments

Labeling changes approved for ELITE LABS INC. Active ingredient: METHADONE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text
  • Previous
  • 10
  • 11
  • 12
  • 13
  • 14
  • Next

Search

News categories

  • Technical Exchange News(12076)
  • Event(5387)
  • SEC News(252248)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(150551)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin